SEI Investments
NMRA icon

SEI Investments’s Neumora Therapeutics NMRA Stock Holding History

SEI Investments’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-68,336
Closed -$124K – 3171
2025
Q3 		$124K Sell
68,336
-145,526
-68% -$235K ﹤0.01% 2690
2025
Q2 		$157K Buy
+213,862
New +$162K ﹤0.01% 2618

Other funds holding NMRA

SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return

SEI Investments's NMRA Position: Q4 2025 in Review

SEI Investments sold out of Neumora Therapeutics (NMRA) in Q4 2025, closing a stake of 68,336 shares — an estimated $124K sold.

SEI Investments first reported a position in NMRA in Q2 2025 and held it in 2 quarters. The position peaked at $157K in Q2 2025. 102 funds tracked by Wall St. Rank hold NMRA as of Q4 2025.

  • SEI Investments reported no remaining Neumora Therapeutics position as of Q4 2025 after selling out during the quarter.
  • SEI Investments sold 68,336 Neumora Therapeutics shares in Q4 2025, an estimated $124K.
  • SEI Investments first reported a position in Neumora Therapeutics in Q2 2025 and held it in 2 quarters.
  • SEI Investments's Neumora Therapeutics position peaked at $157K in Q2 2025.
  • 102 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q4 2025.

Based on SEI Investments's 13F filing for Q4 2025, filed 13 Feb 2026.